These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28988524)

  • 1. Safety of hormonal contraception for obese women.
    Rocha ALL; Campos RR; Miranda MMS; Raspante LBP; Carneiro MM; Vieira CS; Reis FM
    Expert Opin Drug Saf; 2017 Dec; 16(12):1387-1393. PubMed ID: 28988524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Efficacy of Contraceptive Methods for Obese and Overweight Women.
    Lotke PS; Kaneshiro B
    Obstet Gynecol Clin North Am; 2015 Dec; 42(4):647-57. PubMed ID: 26598306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal contraception and obesity.
    Simmons KB; Edelman AB
    Fertil Steril; 2016 Nov; 106(6):1282-1288. PubMed ID: 27565257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal contraception in women at risk of vascular and metabolic disorders: guidelines of the French Society of Endocrinology.
    Gourdy P; Bachelot A; Catteau-Jonard S; Chabbert-Buffet N; Christin-Maître S; Conard J; Fredenrich A; Gompel A; Lamiche-Lorenzini F; Moreau C; Plu-Bureau G; Vambergue A; Vergès B; Kerlan V
    Ann Endocrinol (Paris); 2012 Nov; 73(5):469-87. PubMed ID: 23078975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal contraceptives for contraception in overweight or obese women.
    Lopez LM; Grimes DA; Chen-Mok M; Westhoff C; Edelman A; Helmerhorst FM
    Cochrane Database Syst Rev; 2010 Jul; (7):CD008452. PubMed ID: 20614470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and contraception: metabolic changes, risk of thromboembolism, use of emergency contraceptives, and role of bariatric surgery.
    Gurney EP; Murthy AS
    Minerva Ginecol; 2013 Jun; 65(3):279-88. PubMed ID: 23689170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contraceptive considerations in overweight teens.
    Kaneshiro B; Edelman A
    Curr Opin Obstet Gynecol; 2011 Oct; 23(5):344-9. PubMed ID: 21666461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Contraception and obesity].
    Lobert M; Pigeyre M; Gronier H; Catteau-Jonard S; Robin G
    Gynecol Obstet Fertil; 2015 Nov; 43(11):740-7. PubMed ID: 26527416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined hormonal contraceptive (CHC) use among obese women and contraceptive effectiveness: a systematic review.
    Dragoman MV; Simmons KB; Paulen ME; Curtis KM
    Contraception; 2017 Feb; 95(2):117-129. PubMed ID: 27823942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness and use of hormonal contraceptives (except for intrauterine devices): CNGOF Contraception Guidelines].
    Robin G; Plouvier P; Delesalle AS; Rolland AL
    Gynecol Obstet Fertil Senol; 2018 Dec; 46(12):845-857. PubMed ID: 30413374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity and hormonal contraception: safety and efficacy.
    Edelman AB; Jensen JT
    Semin Reprod Med; 2012 Dec; 30(6):479-85. PubMed ID: 23074006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sexuological impact of hormonal contraceptives based on their route of administration.
    Guida M; Di Carlo C; Troisi J; Gallo A; Cibarelli F; Martini E; Tiranini L; Nappi RE
    Gynecol Endocrinol; 2017 Mar; 33(3):218-222. PubMed ID: 27908210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contraceptive Management for Women Who Are at High Risk of Thrombosis.
    Gray B; Floyd S; James AH
    Clin Obstet Gynecol; 2018 Jun; 61(2):243-249. PubMed ID: 29521659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contraception in women with obesity].
    Ciangura C; Bachelot A
    Med Sci (Paris); 2021 Oct; 37(10):882-887. PubMed ID: 34647876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Hormonal Contraception With Suicide Attempts and Suicides.
    Skovlund CW; Mørch LS; Kessing LV; Lange T; Lidegaard Ø
    Am J Psychiatry; 2018 Apr; 175(4):336-342. PubMed ID: 29145752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception.
    Bentzen JG; Forman JL; Pinborg A; Lidegaard Ø; Larsen EC; Friis-Hansen L; Johannsen TH; Nyboe Andersen A
    Reprod Biomed Online; 2012 Dec; 25(6):612-9. PubMed ID: 23069740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in prescription rates and odds ratios of antidepressant drugs in relation to individual hormonal contraceptives: a nationwide population-based study with age-specific analyses.
    Lindberg M; Foldemo A; Josefsson A; Wiréhn AB
    Eur J Contracept Reprod Health Care; 2012 Apr; 17(2):106-18. PubMed ID: 22385398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity and contraceptive use: impact on cardiovascular risk.
    Rosano GMC; Rodriguez-Martinez MA; Spoletini I; Regidor PA
    ESC Heart Fail; 2022 Dec; 9(6):3761-3767. PubMed ID: 36103980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nondaily hormonal contraception: establishing a fit between product characteristics and patient preferences.
    Levine JP
    J Fam Pract; 2004 Nov; 53(11):904-13. PubMed ID: 15527729
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.